EP0901536B1 - Schallschutzeinrichtung für gleise - Google Patents
Schallschutzeinrichtung für gleise Download PDFInfo
- Publication number
- EP0901536B1 EP0901536B1 EP97922748A EP97922748A EP0901536B1 EP 0901536 B1 EP0901536 B1 EP 0901536B1 EP 97922748 A EP97922748 A EP 97922748A EP 97922748 A EP97922748 A EP 97922748A EP 0901536 B1 EP0901536 B1 EP 0901536B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- slab
- sound
- proofing device
- carrying
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002245 particle Substances 0.000 claims abstract description 17
- 230000002787 reinforcement Effects 0.000 claims abstract description 15
- 239000011230 binding agent Substances 0.000 claims abstract description 11
- 239000004566 building material Substances 0.000 claims abstract 4
- 230000000295 complement effect Effects 0.000 claims description 10
- 238000007373 indentation Methods 0.000 claims description 8
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 230000001788 irregular Effects 0.000 claims description 3
- 238000005096 rolling process Methods 0.000 claims description 3
- 230000000284 resting effect Effects 0.000 claims 12
- 230000002238 attenuated effect Effects 0.000 claims 1
- 230000030279 gene silencing Effects 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 230000002349 favourable effect Effects 0.000 description 5
- 239000003562 lightweight material Substances 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 229910000831 Steel Inorganic materials 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000005304 joining Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000010959 steel Substances 0.000 description 3
- 229920002430 Fibre-reinforced plastic Polymers 0.000 description 2
- 239000011358 absorbing material Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000011151 fibre-reinforced plastic Substances 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000011490 mineral wool Substances 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 229920000426 Microplastic Polymers 0.000 description 1
- 229920002522 Wood fibre Polymers 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000011900 installation process Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002025 wood fiber Substances 0.000 description 1
Images
Classifications
-
- E—FIXED CONSTRUCTIONS
- E01—CONSTRUCTION OF ROADS, RAILWAYS, OR BRIDGES
- E01B—PERMANENT WAY; PERMANENT-WAY TOOLS; MACHINES FOR MAKING RAILWAYS OF ALL KINDS
- E01B19/00—Protection of permanent way against development of dust or against the effect of wind, sun, frost, or corrosion; Means to reduce development of noise
- E01B19/003—Means for reducing the development or propagation of noise
Definitions
- the invention relates to a soundproofing device for tracks, on the rails the sound-absorbing plates mounted on the track, which have elastic profiles the rails are supported, the plates arranged between the rails Bridge the space between the rails in a self-supporting manner.
- the invention further relates on sound absorbing panels for such a soundproofing device.
- the plates arranged between the rails of the track consist of three layers or layers that extend over elastic profiles on the rail foot, Support the web and the underside of the head.
- the upper layer consists of steel wire mesh, the edge of which is glued, welded or vulcanized into the profile.
- the middle layer is designed as a sound absorption layer and consists of glass wool or rock wool. This sound absorption layer lies on the lower layer, which is designed as a perforated wall or grate and is supported in a recess in the profile in the region of the rail foot.
- the plates are also arranged on the outside of the rail and angled upward at the ends in order to form a lateral soundproofing wall.
- Such mineral wool panels have sufficient sound absorption at high frequencies, but have inadequate sound insulation at low frequencies.
- Another disadvantage of this construction is that the walkable perforated wall made of steel wire mesh can become detached from its anchoring in the profiles at higher and repeated loads, so that the sound absorption layer underneath can be damaged.
- the dust penetrating through the perforated wall can be deposited on the top of the sound absorption layer and thus the sound damping effect can deteriorate progressively.
- a soundproofing device for tracks is known in which panels made of wood fiber concrete are arranged between the rails of the track, which rest on the sleepers of the track and laterally more elastic with an intermediate layer Lay strips on the rails. There is no unsupported storage of these plates.
- the invention has for its object to provide a soundproofing device for tracks sound-absorbing panels to create a good sound absorption or damping over the entire frequency range essential for the sound level of rail traffic has, with a permanent mechanical Strength of the device should be guaranteed.
- the soundproofing device initially mentioned type according to the invention solved in that the Plates consist of particles made of porous lightweight material, which are connected at certain points with a binder, and that the Slabs have embedded reinforcement and are uncovered are.
- the above can Objectives are met well.
- the particular of the wheels of a rail vehicle and from the rails Airborne sound is emitted from the surface of the panels
- Pores of the particles are absorbed and can also fine spaces between the particles, leaving the structure through spaces or channels between the particles penetrate deeper into the plate to gradually complete there to be subdued. Due to the reinforcement of the slabs too ensures their accessibility.
- the plates is advantageously provided that the top of the panels is textured, being even better Results can be achieved if the structuring is irregular is.
- the top of the plates is preferably parallel to the rails extending ribs, whereby a structurally simple to manufacture results.
- the ribs have a trapezoidal shape Have a cross-section, as this means that the angle falls Sound waves can be better absorbed.
- the wall of the cavity resonators and their sound openings with a sound absorbing structure are provided, and / or if the wall of the cavity resonators and their tubular sound openings with a sound-absorbing layer are provided.
- the cavities forming the cavities after are designed to be open at the bottom and with a lower plate are covered.
- the cavity resonators forming cavities open downwards are trained and together with the track bed Form resonance cavity.
- the damped resonance frequency of the cavity resonators within a frequency range from 150 to 1000 Hz, preferably is between 500 and 1000 Hz.
- a special embodiment is also within the scope of the invention provided in which the installation and removal the one to be provided between the two rails of a track Plates can be done in a very simple way.
- This embodiment of the soundproofing device is thereby characterized in that the one between the two rails
- the track lying space is bridged with partial plates arranged in pairs is, each with at least one support rib in the Latch chambers of the rails engage, the partial plates each pair of plates on their mutually facing edges are supported on each other and in this case with each partial plate meandering along the edge facing the other partial plate alternating successive support sections and support sections are provided, wherein the support sections through by the Outgoing plate top and up to the other partial plate facing depressions are formed and under the supporting sections starting from the underside of the plate Indentations above are formed, which are complementary are formed to the depressions of the support sections, and the Supporting sections of a partial plate on the support sections of the other sub-plate and the support sections of the other sub-plate rest on the support sections of a partial plate.
- Plate pairs can be used when the partial plates are unfolded simply put together, after which the partial panels are no problem leveling the pair of plates between the rails can be inserted, and it will also be the sub-panels Loads not pushed apart.
- a preferred type of the latter embodiment which is characterized in that on those surfaces which the partial plates of a plate pair lie against each other, Projections and depressions shaped complementary to the projections, in which the projections snap into place for mutual Locking of the partial plates are provided, has the advantage that the cohesion of the partial plates of a plate pair also is secured over a very long period of time even when unfavorable Vibrations affect the sub-panels.
- Such a crowning can be on one Partial plate by one, of which the other partial plate of the Plate pair facing edge outgoing surface section, the extending from the underside of the plate, and a subsequent surface section, which is the bottom approaching the plate are formed. If you want one such formation of the sub-plates additionally a latching it is advantageous if you train them to that down at the end edges of the support sections pointing projections and on the wings of the support sections complementary depressions are provided for these projections.
- the domed wings are shaped according to a toothing, which up to for leveling the position of the partial plates of the respective plate pair a sliding movement or rolling movement of each other facing wings and supporting surfaces on each other and in the leveled position of these partial plates against one Movement of these partial plates to each other blocks.
- Partial plates favorable geometry, if one provides that the partial plates on the mutually facing edges from the underside of the plate starting from the top to be rounded, whereby the radius of curvature is equal to or less than the distance between these edges and the rail side edges of the Is partial panels. It is also a simple assembly the partial plates of a plate pair advantageous, if one provides that the two partial plates of a pair of plates on the underside of the plate approximately along a straight line apart. However, if you want the highest possible load capacity of the plate pair, it is favorable if one provides that the two partial plates of a plate pair on the The underside of the plate should be meandering.
- the reinforcement provided in the sub-slabs changes extends over the plate surface and into the support sections and engages in the support sections and in the support ribs. It is also cheap if you provide that between the on the support sections provided wings and on the support sections provided support surfaces an elastic and / or shock-absorbing insert or coating is provided.
- a sound absorbing plate according to the invention is thereby characterized in that the plate is made of porous particles
- Lightweight material is made, which is connected at certain points with a binder are that the plate on opposite edges with support ribs for engaging in the link chambers of rails, that the plate has an embedded surface reinforcement, and that in the plate cavity resonators with one Large area of the plate directed tubular sound openings, whose cross section is significantly smaller than the cross section of the cavity resonators, are formed, which large area to form the top is provided when installing the plate in the track.
- Hiebei is it is advantageous if those forming the cavity resonators Cavities to the large area that the tubular Side of the plate facing away from the sound openings, expanding are openly trained.
- Embodiments of a plate designed according to the invention which for the aforementioned Training with partial plates to be assembled into a pair of plates are provided, are characterized in that the Plate consists of particles made of porous lightweight material, which with a binder are put together so that the plate is an embedded Reinforcement has that the plate on one edge side with a support rib for engaging in the tab chambers of Rails is provided and on the opposite of this support rib Edge side in meandering succession of supporting sections and has support portions, the support portions by starting from the top of the plate and up to the edge reaching depressions are formed and under the support sections starting from the underside of the plate, facing upwards Depressions are formed, which are complementary to the Depressions of the support sections are shaped.
- the plate cavity resonators with a large area of the plate directed tubular sound openings are formed, which large area to form the Top is provided when installing the plate in the track. It is further advantageous if the provided in the plate Reinforcement extends over the entire slab area and in the support sections and in the support sections and in the Rib is enough. If desired, the plates or partial plates also with a preferably running along the edge made of metal or fiber-reinforced plastic, Frame.
- the generally rectangular Plates 3 have the rails 2 along both of them extending edges projecting support ribs 4, which with the interposition of elastic profiles 5, e.g. made of rubber or elastomer, on the rail base 6, on the rail web 7 and on the Support the underside of the rail head 8 of the rails 2.
- a lightweight material used for example plastic granules, granular or spherical and fired alumina particles, granular slag particles, or similar burned natural or artificial manufactured materials
- these particles with a suitable Plastic binders or cement are connected at certain points, so that small gaps or channels 10 remain, one Air shutter pipe and a drain of penetrating rain or Allow melt water.
- the one on the plates 3 impinging airborne sound is on the surface of the plates 3 absorbed by the pores of the particles 9 and can via the gaps or channels remaining between the particles 9 10 penetrate deeper into the plate 3 to gradually be absorbed there to become.
- the surface of the plates 3 by structuring be enlarged.
- the top 12 of the Plates 3 with parallel to the rails 2 and in Spaced ribs 13 may be provided, which, as shown in Figure 3, a trapezoidal cross-section and have a height a above the rail head 8, which is a permissible Value of e.g. Not exceed 5 cm.
- the structuring can also be irregular, e.g. the distance of the Ribs 13 increases or decreases relative to each other.
- the Top 12 can also, for example, truncated cones, truncated pyramids, Cylinders, cuboids, etc. can be provided either in the same or at different distances from each other are.
- the tubular sound openings 15 are provided on the top 12 of the plates 3.
- the cavity resonators 14 forming cavities frusto-conical and down formed open, the openings thus formed through one, e.g. glued to the plate 3, sub-plate 16 covered are to form the cavity resonator 14.
- the cavities forming the cavity resonators left open at the bottom so that it can be the only shown schematically with a dash-dotted line Track bed 17 (e.g.
- the cavities forming cavities 14 can also be of the Conical shape different, e.g. spherical, cylindrical, pyramid-shaped, etc. to be different To achieve frequency behavior in sound absorption.
- the volumes of the cavity resonators 14 and Dimensions of the tubular sound openings can be varied in order the desired frequency response or frequency absorption spectrum to achieve.
- the tubular sound openings 15 open, as shown in Figure 2, perpendicular to the top 12 of the plate 3. In a variation of this arrangement, the tubular sound openings 15 also open at an angle to the top 12 of the plates 3, to better absorb oblique sound waves.
- the manufacture of the plates 3 with the cavity resonators 14 can be done in a rectangular shape, in the positive shapes the cavity resonators with attached pipe pieces for the sound openings are used, whereupon the shape with the Particle 9 and a binder filled and after curing of the binder is removed from the mold.
- too prefabricated cavity resonators with attached pipe sections can be used as a sound opening in the form, either consist of a suitable sound absorbing material or provided with a layer of sound-absorbing material on the inside are.
- the rails 2 can also on the outside of the rail the rails 2 sound absorbing plates with cavity resonators be provided.
- the one on the right rail 2 Plate 18 shown with a dash-dotted line is on one End, similar to the plate 3 lying between rails 2 the rail 2 via an elastic profile 5 and at the other end supported by an elastic strip 19 and by means of a Fastening element, in particular a screw 20, fixed.
- the one on the left rail 2, also with dash-dotted lines Plate 21 shown in line is the same as that Plate 18 supported and fixed, but has one on the outside end area bent at the top to create a soundproof wall form.
- the two plates 18, 21 also have reinforcement (not shown) and, if necessary, structuring in the form of ribs (not shown). If desired, you can also use a plate that runs along the edge Frame.
- a soundproofing device designed according to the invention the space between the two rails 2 of a track 1 22 with paired sound-absorbing partial plates 3a, 3b filled or bridged.
- These partial plates 3a, 3b have Support ribs 4, which in the tab chambers 23 of the rails 2nd intervene, and there are between the support ribs 4 and Rails 2 elastic profiles 5 with an approximately C-shaped cross section inserted.
- the partial plates 3a, 3b are included their support ribs 4 on the rail base 6 and laterally against the Rail web 7 supported and upwards by engagement under held the rail head 8.
- Bridge the partial plates 3a, 3b the distance 24 between the rails 2 is self-supporting.
- each of the partial plates 3a, 3b is provided with a plurality of supporting ribs 4, which are spaced from each other by the for the Rails 2 provided fasteners 25 accessible to let. But you can also choose a different plate size and panel mounting arrangement on each panel as well provide only one support rib 4.
- each partial plate 3a and 3b along the the other partial plate 3b or 3a facing edge 15 or 16 meandering alternating successive support sections 28th and support sections 29 are provided, the support sections 28 through depressions 30 starting from the top 12 of the plate are formed, which face up to that of the other partial plate Reach the edge; under the support sections 29 are of the Plate underside 31 outgoing, upward, depressions 32 formed, and there are the support portions of the Sub-plate 3a on the support portions of sub-plate 3b and Supporting sections of the partial plate 3b on the support sections of the Partial plate 3a on; the depressions 30 are to the depressions 32 designed complementary, so that on the support sections 29 formed by the depressions 32 support surfaces 34 in substantially full on the through the depressions 30 on the Support sections 28 formed wings 33 rest.
- the wings 33 provided in the support sections 28 have a cambered shape, and there is such a cambered Shape also in the support surfaces provided on the support sections 29 34 before, and it is due to this cambered form of the above Surfaces create a form cohesion of the partial plates 3a, 3b, which in the leveled position of the partial plates 3a, 3b a mutual movement of these partial plates in the direction the plate level (arrows 36) inhibits. Furthermore, are on the support surfaces 34 projections 37 and 33 wells on the wings 38, which are complementary to the projections 37, provided; in the leveled position of the partial plates, the Projections 37 into the recesses 38 so that there is a mutual locking of the partial plates 3a, 3b results.
- an elastic and / or shock-braking effect Inlay or coating can be provided.
- the wings 33 provided on the support sections extend from the edge 26 or 27 of the relevant sub-plate 3a or 3b starting, first steep away from the underside 31 of the plate rising and then flattening, what kind of joining the partial plates to the plate pairs is advantageous. Geometric seen it is favorable if such a domed shape Wings are shaped according to a toothing, which up to the leveled position of the partial plates 3a, 3b of the respective Plate pair a sliding movement or rolling movement of the wings and support surfaces facing each other enables, and in the leveled position (Fig. 5 to 7) locks these partial plates against movement to one another. This surface shape corresponding geometrically to a toothing can extend to the top of the plate 12.
- the projections 37 can, as shown in FIGS. 5 to 8, provided on the end edges 39 of the support sections 29 be what brings advantages when joining the sub-panels may, but it is also possible to such projections 37 on others Position, e.g. slightly moved away from the edge of the support surfaces.
- Both in the embodiment shown in Figures 5 to 7 as well as in the variant shown in Fig.10 are the two partial plates 3a, 3b of a plate pair on the Underside of plate 31 interlocking, so that the mutually facing edges of the partial plates 3a, 3b run along the underside of the plate following a meandering line 43. This results in a very close bond of the partial plates 3a, 3b forming a pair of plates.
- FIGS. 11 to 16 are the partial plates 3a, 3b on the mutually facing edges 26, 27 starting from the underside of the plate 31 rounded upwards shaped, the radius of curvature of this rounding equal to or less than the distance 41 between the Edges 26, 27 and the rail-side edges 42 of the partial plates 3a, 3b. This measure is also possible for you uninhibited process of inserting the partial panels advantageous.
- the reinforcement 11 provided in the sub-slabs over the whole surface extension of the partial plates 3a, 3b is sufficient and here, as indicated by the broken line in FIG. 8, both in the support sections 28 and in the support sections 29 as well as in the support ribs 4 engages.
Landscapes
- Engineering & Computer Science (AREA)
- Architecture (AREA)
- Civil Engineering (AREA)
- Structural Engineering (AREA)
- Building Environments (AREA)
- Soundproofing, Sound Blocking, And Sound Damping (AREA)
- Railway Tracks (AREA)
- Power-Operated Mechanisms For Wings (AREA)
- Devices Affording Protection Of Roads Or Walls For Sound Insulation (AREA)
- Signal Processing Not Specific To The Method Of Recording And Reproducing (AREA)
- Noise Elimination (AREA)
- Magnetic Heads (AREA)
- Holo Graphy (AREA)
- Fittings On The Vehicle Exterior For Carrying Loads, And Devices For Holding Or Mounting Articles (AREA)
- Bridges Or Land Bridges (AREA)
Description
-steg und an der -kopfunterseite abstützen. Die obere Lage besteht aus begehbarem Stahldrahtgewebe, deren Rand in das Profil eingeklebt, eingeschweißt oder einvulkanisiert ist. Die mittlere Lage ist als Schallabsorptionsschicht ausgebildet und besteht aus Glaswolle oder Steinwolle. Diese Schallabsorptionsschicht liegt auf der unteren Lage auf, welche als Lochwand oder Rost ausgebildet und in einer Ausnehmung des Profiles im Bereich des Schienenfußes abgestützt ist. Gemäß einer weiteren Ausführungsform sind die Platten auch an der Schienenaußenseite angeordnet und an den Enden nach oben abgewinkelt, um eine seitliche Schallschutzwand zu bilden. Solche Platten aus Mineralwolle weisen zwar bei hohen Frequenzen eine ausreichende Schalldämpfung auf, haben aber bei tiefen Frequenzen eine ungenügende Schalldämpfung. Weiters ist bei dieser Konstruktion von Nachteil, daß sich die begehbare Lochwand aus Stahldrahtgewebe bei einer höheren und mehrmaligen Belastung aus ihrer Verankerung in den Profilen lösen kann, so daß die darunterliegende Schallabsorptionsschicht beschädigt werden kann. Außerdem kann sich auf der Oberseite der Schallabsorptionsschicht der durch die Lochwand durchdringende Staub ablagern und somit die Schalldämpfungswirkung zunehmend verschlechtern.
Claims (28)
- Schallschutzeinrichtung für Gleise, mit an den Schienen des Gleises gelagerten Schall absorbierenden Platten, welche über elastische Profile an den Schienen abgestützt sind, wobei die zwischen den Schienen angeordneten Platten den Raum zwischen den Schienen von Schiene zu Schiene ausschließlich freitragend überbrückend gelagert sind, dadurch gekennzeichnet, daß die Platten (3; 18; 21) aus Teilchen (9) aus porösem Leichtbauwerkstoff bestehen, die mit einem Bindemittel punktuell verbunden sind, und daß die Platten (3; 18; 21) eine eingebettete Flächenbewehrung (11) aufweisen und unbedeckt angeordnet sind.
- Schallschutzeinrichtung nach Anspruch 1, dadurch gekennzeichnet, daß die Oberseite (12) der Platten (3; 18; 21) strukturiert ist.
- Schallschutzeinrichtung nach Anspruch 2, dadurch gekennzeichnet, daß die Strukturierung unregelmäßig ist.
- Schallschutzeinrichtung nach Anspruch 2 oder 3, dadurch gekennzeichnet, daß die Oberseite der Platten (3; 18; 21) mit parallel zu den Schienen (2) verlaufenden Rippen (13) versehen ist.
- Schallschutzeinrichtung nach Anspruch 4, dadurch gekennzeichnet, daß die Rippen (13) einen trapezförmigen Querschnitt aufweisen.
- Schallschutzeinrichtung nach einem der Ansprüche 1 bis 5, dadurch gekennzeichnet, daß in den Platten (3) Hohlraumresonatoren (14) mit zur Oberseite (12) der Platten (3; 18; 21) gerichteten rohrförmigen Schallöffnungen (15) ausgebildet sind.
- Schallschutzeinrichtung nach Anspruch 6, dadurch gekennzeichnet, daß die Wandungen der Hohlraumresonatoren (14) und deren Schallöffnungen (15) mit einer schalldämpfenden Strukturierung versehen sind.
- Schallschutzeinrichtung nach Anspruch 6, dadurch gekennzeichnet, daß die Wandungen der Hohlraumresonatoren (14) und deren rohrförmige Schallöffnungen (15) mit einer schalldämpfenden Schicht versehen sind.
- Schallschutzeinrichtung nach einem der Ansprüche 6 bis 8, dadurch gekennzeichnet, daß die die Hohlraumresonatoren (14) bildenden Hohlräume nach unten erweiternd offen ausgebildet sind und mit einer Unterplatte (16) abgedeckt sind.
- Schallschutzeinrichtung nach einem der Ansprüche 6 bis 8, dadurch gekennzeichnet, daß die die Hohlraumresonatoren (14) bildenden Hohlräume nach unten erweiternd offen ausgebildet sind und zusammen mit dem zwischen Gleisbettung (17) und der Unterseite der betreffenden Platte (3) befindlichen Raum einen Resonanzhohlraum bilden.
- Schallschutzeinrichtung nach einem der Ansprüche 6 bis 10, dadurch gekennzeichnet, daß die gedämpfte Resonanzfrequenz der Hohlraumresonatoren (14) in einem Frequenzbereich von 150 bis 1000 Hz, vorzugsweise zwischen 500 und 1000 Hz, liegt.
- Schallschutzeinrichtung nach einem der Ansprüche 1 bis 11, dadurch gekennzeichnet, daß der zwischen den beiden Schienen (2) eines Gleises (1) liegende Raum (22) mit paarig angeordneten Teilplatten (3a, 3b) überbrückt ist, welche je mit mindestens einer Tragrippe (4) in die Laschenkammern (23) der Schienen (2) eingreifen, wobei die Teilplatten (3a, 3b) jedes Plattenpaares an ihren einander zugekehrten Rändern (26, 27) aufeinander abgestützt sind und hierbei bei jeder Teilplatte längs des der anderen Teilplatte zugekehrten Randes mäanderartig abwechselnd aufeinanderfolgend Tragabschnitte (28) und Stützabschnitte (29) vorgesehen sind, wobei die Tragabschnitte durch von der Plattenoberseite (12) ausgehende und bis zum der anderen Teilplatte zugekehrten Rand reichende Einsenkungen (30) gebildet sind und unter den Stützabschnitten (29) von der Plattenunterseite (31) ausgehende, nach oben gerichtete Einsenkungen (32) gebildet sind, welche komplementär zu den Einsenkungen der Tragabschnitte geformt sind, und die Stützabschnitte der einen Teilplatte auf den Tragabschnitten der anderen Teilplatte sowie die Stützabschnitte der anderen Teilplatte auf den Tragabschnitten der einen Teilplatte aufliegen.
- Schallschutzeinrichtung nach Anspruch 12, dadurch gekennzeichnet, daß an jenen Flächen (33, 34), an denen die Teilplatten (3a, 3b) eines Plattenpaares aneinanderliegen, Vorsprünge (37) und komplementär zu den Vorsprüngen geformte Vertiefungen (38), in welche die Vorsprünge einrasten, zur gegenseitigen Verrastung der Teilplatten (3a, 3b) vorgesehen sind.
- Schallschutzeinrichtung nach Anspruch 12 oder 13, dadurch gekennzeichnet, daß die in den Tragabschnitten (28) vorgesehenen Tragflächen (33) von dem der anderen Teilplatte des Plattenpaares zugewandten Rand ausgehend von der Plattenunterseite (31) weg zuerst steil ansteigend und dann flacher werdend geformt sind.
- Schallschutzeinrichtung nach Anspruch 14, dadurch gekennzeichnet, daß die in den Tragabschnitten (28) vorgesehenen Tragflächen (33) eine bombierte Form haben, welche in der eingeebneten Stellung der Teilplatten (3a, 3b) des jeweiligen Plattenpaares eine gegenseitige Bewegung dieser Teilplatten (3a, 3b) in Richtung der Plattenebene (36) hemmt.
- Schallschutzeinrichtung nach Anspruch 13 und Anspruch 14 oder 15, dadurch gekennzeichnet, daß an den Stirnrändern (39) der Stützabschnitte (29) nach unten weisende Vorsprünge (37) und an den Tragflächen (33) der Tragabschnitte (28) zu diesen Vorsprüngen (37) komplementäre Vertiefungen (38) vorgesehen sind.
- Schallschutzeinrichtung nach Anspruch 15, dadurch gekennzeichnet, daß die bombiert geformten Tragflächen (33) entsprechend einer Verzahnung geformt sind, welche bis zur eingeebneten Stellung der Teilplatten (3a, 3b) des jeweiligen Plattenpaares eine Gleitbewegung oder Abrollbewegung der einander zugekehrten Tragflächen und Stützflächen aufeinander ermöglicht und in der eingeebneten Stellung dieser Teilplatten gegen eine Bewegung dieser Teilplatten zueinander sperrt.
- Schallschutzeinrichtung nach einem der Ansprüche 12 bis 17, dadurch gekennzeichnet, daß die Teilplatten (3a, 3b) an den einander zugewandten Rändern (26, 27) von der Plattenunterseite (31) ausgehend nach oben zu abgerundet geformt sind, wobei der Krümmungsradius gleich groß wie oder kleiner als der Abstand (41) zwischen diesen Rändern (26, 27) und den schienenseitigen Rändern (42) der Teilplatten (3a, 3b) ist.
- Schallschutzeinrichtung nach einem der Ansprüche 12 bis 18, dadurch gekennzeichnet, daß die beiden Teilplatten (3a, 3b) eines Plattenpaares an der Plattenunterseite (31) annähernd längs einer Geraden (40) aneinanderliegen.
- Schallschutzeinrichtung nach einem der Ansprüche 12 bis 18, dadurch gekennzeichnet, daß die beiden Teilplatten (3a, 3b) eines Plattenpaares an der Plattenunterseite (31) mäanderartig ineinandergreifend aneinanderliegen.
- Schallschutzeinrichtung nach einem der Ansprüche 12 bis 20, dadurch gekennzeichnet, daß die in den Teilplatten (3a, 3b) vorgesehene Bewehrung (11) sich über die Plattenfläche (36) erstreckt und in die Tragabschnitte (28) und in die Stützabschnitte (29) sowie in die Tragrippen (4) eingreift.
- Schallschutzeinrichtung nach einem der Ansprüche 12 bis 21, dadurch gekennzeichnet, daß zwischen den an den Tragabschnitten vorgesehenen Tragflächen (33) und den an den Stützabschnitten vorgesehenen Stützflächen (34) eine elastisch und/oder Stoß bremsend wirkende Einlage oder Beschichtung vorgesehen ist.
- Schallabsorbierende Platte für eine Schallschutzeinrichtung nach einem der Ansprüche 1 bis 22, dadurch gekennzeichnet, daß die Platte (3; 18; 21) aus Teilchen (9) aus porösem Leichtbauwerkstoff besteht, die mit einem Bindemittel punktuell verbunden sind, daß die Platte (3) an gegenüberliegenden Randseiten mit Tragrippen (4) zum Eingriff in die Laschenkammern von Schienen versehen ist, daß die Platte (3; 18; 21) eine eingebettete Flächenbewehrung (11) aufweist, und daß in der Platte (3; 18; 21) Hohlraumresonatoren (14) mit zur einen Großfläche der Platte (3; 18; 21) gerichteten rohrförmigen Schallöffnungen (15), deren Querschnitt wesentlich geringer als der Querschnitt der Hohlraumresonatoren ist, ausgebildet sind, welche Großfläche zur Bildung der Oberseite beim Einbau der Platte in das Gleis vorgesehen ist.
- Schallabsorbierende Platte nach Anspruch 23, dadurch gekennzeichnet, daß die die Hohlraumresonatoren (14) bildenden Hohlräume zu jener Großfläche hin, die an der den rohrförmigen Schallöffnungen (15) abgewandten Seite der Platte liegt, erweiternd offen ausgebildet sind.
- Schallabsorbierende Platte nach Anspruch 24, dadurch gekennzeichnet, daß die die Hohlraumresonatoren (14) bildenden Hohlräume an der den rohrförmigen Schallöffnungen (15) abgewandten Seite mit einer Unterplatte (16) abgedeckt sind.
- Schallabsorbierende Platte für eine Schallschutzeinrichtung nach einem der Ansprüche 12 bis 22, dadurch gekennzeichnet, daß die Platte (3a, 3b) aus Teilchen aus porösem Leichtbaustoff besteht, die mit einem Bindemittel zusammengefügt sind, daß die Platte (3a, 3b) eine eingebettete Bewehrung aufweist, daß die Platte (3a, 3b) an einer Randseite mit einer Tragrippe (4) zum Eingriff in die Laschenkammern von Schienen versehen ist und an der dieser Tragrippe (4) gegenüberliegenden Randseite in mäanderartiger Aufeinanderfolge Tragabschnitte (28) und Stützabschnitte (29) aufweist, wobei die Tragabschnitte durch von der Plattenoberseite (12) ausgehende und bis zum Rand reichende Einsenkungen (30) gebildet sind und unter den Stützabschnitten (29) von der Plattenunterseite (31) ausgehende, nach oben gerichtete Einsenkungen (32) gebildet sind, welche komplementär zu den Einsenkungen der Tragabschnitte geformt sind.
- Schallabsorbierende Platte nach Anspruch 26, dadurch gekennzeichnet, daß in der Platte (3a, 3b) Hohlraumresonatoren (14) mit zur einen Großfläche der Platte (3a, 3b) gerichteten rohrförmigen Schallöffnungen (15) ausgebildet sind, welche Großfläche zur Bildung der Oberseite beim Einbau der Platte in das Gleis vorgesehen ist.
- Schallabsorbierende Platte nach Anspruch 26 oder 27, dadurch gekennzeichnet, daß die in der Platte (3a, 3b) vorgesehene Bewehrung (11) sich über die ganze Plattenfläche erstreckt und in die Tragabschnitte (28) und in die Stützabschnitte (29) sowie in die Tragrippe (4) reicht.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SI9730491T SI0901536T1 (en) | 1996-05-29 | 1997-05-23 | Track soundproofing arrangement |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT93496A AT403809B (de) | 1996-05-29 | 1996-05-29 | Schallschutzeinrichtung für gleise |
| AT93496 | 1996-05-29 | ||
| AT934/96 | 1996-06-11 | ||
| AT1015/96 | 1996-06-11 | ||
| AT101596 | 1996-06-11 | ||
| AT0101596A AT405426B (de) | 1996-06-11 | 1996-06-11 | Schienengleiche eindeckung für gleise |
| PCT/AT1997/000109 WO1997045592A1 (de) | 1996-05-29 | 1997-05-23 | Schallschutzeinrichtung für gleise |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0901536A1 EP0901536A1 (de) | 1999-03-17 |
| EP0901536B1 true EP0901536B1 (de) | 2002-12-11 |
Family
ID=25594370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP97922748A Expired - Lifetime EP0901536B1 (de) | 1996-05-29 | 1997-05-23 | Schallschutzeinrichtung für gleise |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6253872B1 (de) |
| EP (1) | EP0901536B1 (de) |
| JP (1) | JP3822641B2 (de) |
| CN (1) | CN100424268C (de) |
| AT (1) | ATE229595T1 (de) |
| AU (1) | AU738889B2 (de) |
| CA (1) | CA2255946C (de) |
| DE (1) | DE59708955D1 (de) |
| DK (1) | DK0901536T3 (de) |
| ES (1) | ES2186891T3 (de) |
| HU (1) | HU221872B1 (de) |
| NO (1) | NO316078B1 (de) |
| TW (1) | TW345603B (de) |
| WO (1) | WO1997045592A1 (de) |
Families Citing this family (311)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19812481C2 (de) * | 1998-03-21 | 2002-08-22 | Johann Rath | Vorrichtung zur Dämpfung von Schallemissionen an Gleisanlagen |
| DE29905550U1 (de) * | 1999-03-26 | 2000-08-24 | DVG Deutsche Verpackungsmittel GmbH, 90552 Röthenbach | Absorptionsbelag zur Reduzierung der Schallabstrahlung für Gleiskörper |
| US7897140B2 (en) | 1999-12-23 | 2011-03-01 | Health Research, Inc. | Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents |
| US6481637B1 (en) * | 2000-11-20 | 2002-11-19 | Mcqueen Philip Jeffrey | Rail pad and method for strain attentuation |
| DE10111919A1 (de) * | 2001-03-13 | 2002-09-19 | Boegl Max Bauunternehmung Gmbh | Fahrwegträger |
| HU224236B1 (hu) * | 2001-12-14 | 2005-06-28 | Attila Szebeni | Vasúti acélhidaknál alkalmazható, egymáshoz csatlakoztatott elemekbõl álló, zaj- és rezgéscsökkentett mûanyag járólemezrendszer |
| US8829198B2 (en) | 2007-10-31 | 2014-09-09 | Proteotech Inc | Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies |
| AU2003248747A1 (en) | 2002-06-27 | 2004-01-19 | Health Research, Inc. | Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| WO2004005289A2 (en) | 2002-07-02 | 2004-01-15 | Health Research, Inc. | Efficient synthesis of pyropheophorbide a and its derivatives |
| AT6414U1 (de) * | 2002-07-17 | 2003-10-27 | Gmundner Fertigteile Gmbh | Gleisabdeckung |
| GB2399123B (en) * | 2003-03-05 | 2006-03-01 | Corus Uk Ltd | Rail damper |
| WO2004099162A1 (en) * | 2003-04-30 | 2004-11-18 | Ricerca Biosciences, Llc. | Polycyclic diazodioxide-based bcl-2 protein antagonist |
| US20040242886A1 (en) * | 2003-04-30 | 2004-12-02 | Sandeep Gupta | Monocyclic diazodioxide based Bcl-2 protein antagonists related applications |
| EP1628666B1 (de) * | 2003-05-14 | 2015-09-23 | NeuroGenetic Pharmaceuticals, Inc. | Verbindungen und ihre verwendungen zur modulierung von amyloid beta |
| US8916598B2 (en) | 2003-05-30 | 2014-12-23 | Proteotech Inc | Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies |
| US20100331380A1 (en) * | 2009-06-29 | 2010-12-30 | Esposito Luke A | Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies |
| WO2005090370A1 (en) | 2004-02-05 | 2005-09-29 | The Regents Of The University Of California | Pharmacologically active agents containing esterified phosphonates and methods for use thereof |
| US20100126797A1 (en) * | 2004-02-12 | 2010-05-27 | Humphries Eric C | Panel Assembly For Traffic Noise Barrier Wall |
| US8616331B2 (en) | 2004-02-12 | 2013-12-31 | Eric C. Humphries | Panel assembly for traffic noise barrier wall |
| US7546900B2 (en) * | 2004-02-12 | 2009-06-16 | Evonik Cyro Llc | Panel assembly for traffic noise barrier wall |
| TWI347390B (en) * | 2004-03-05 | 2011-08-21 | Gmundner Fertigteile Gmbh | Noise-reducing track cover |
| JP2007538103A (ja) | 2004-05-20 | 2007-12-27 | ザ スクリップス リサーチ インスティテュート | トランスサイレチン安定化 |
| NZ588432A (en) | 2004-09-17 | 2012-03-30 | Whitehead Biomedical Inst | Compounds, Compositions and Methods of Inhibiting Alpha-Synuclein Toxicity |
| US20060067889A1 (en) * | 2004-09-27 | 2006-03-30 | Light Sciences Corporation | Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents |
| US20070131480A1 (en) * | 2004-12-06 | 2007-06-14 | Corbin Maxwell H Jr | Sound arresting barrier |
| US7464791B2 (en) * | 2005-01-27 | 2008-12-16 | Pretty Products, Llc | Acoustic mats and methods for making the same |
| US20060230699A1 (en) * | 2005-03-22 | 2006-10-19 | Keene James R | Sound control flooring systems and methods therefor |
| EP1866319B1 (de) | 2005-04-01 | 2011-11-23 | The Regents of The University of California | Phosphono-pent-2-en-1-yl-nukleoside und analoga |
| US20090156545A1 (en) * | 2005-04-01 | 2009-06-18 | Hostetler Karl Y | Substituted Phosphate Esters of Nucleoside Phosphonates |
| US8492428B2 (en) * | 2005-09-20 | 2013-07-23 | Mayo Foundation For Medical Education And Research | Small-molecule botulinum toxin inhibitors |
| US8138361B2 (en) * | 2005-12-28 | 2012-03-20 | The Trustees Of The University Of Pennsylvania | C-10 carbamates of taxanes |
| WO2007106537A2 (en) * | 2006-03-13 | 2007-09-20 | Activx Biosciences, Inc. | Aminoquinolones as gsk-3 inhibitors |
| EP2007373A4 (de) * | 2006-03-29 | 2012-12-19 | Foldrx Pharmaceuticals Inc | Hemmung der alpha-synuclein-toxizität |
| AU2007260579B2 (en) * | 2006-06-13 | 2012-09-06 | Newstyle Nominees Pty Ltd | Rail track crossing |
| EA021255B1 (ru) | 2006-08-28 | 2015-05-29 | Киова Хакко Кирин Ко., Лимитед | Антагонистические моноклональные антитела человека, специфичные в отношении light человека |
| CN101535304A (zh) | 2006-09-21 | 2009-09-16 | 埃迪威克斯生物科学公司 | 丝氨酸水解酶抑制剂 |
| BRPI0715579A2 (pt) | 2006-10-19 | 2015-05-26 | Auspex Pharmaceuticals Inc | "composto, composição farmacêutica e uso de um composto" |
| JP5013590B2 (ja) * | 2006-11-14 | 2012-08-29 | エンデバーハウス株式会社 | 伸縮性に優れた線路用吸音材 |
| US20080146605A1 (en) | 2006-12-19 | 2008-06-19 | Auspex Pharmaceuticals, Inc. | Preparation and utility of ccr5 inhibitors |
| WO2008079371A1 (en) * | 2006-12-22 | 2008-07-03 | Encysive Pharmaceuticals, Inc. | Modulators of c3a receptor and methods of use thereof |
| WO2008106167A1 (en) * | 2007-02-28 | 2008-09-04 | Conatus Pharmaceuticals, Inc. | Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases |
| BRPI0808089A2 (pt) | 2007-02-28 | 2014-07-15 | Conatus Pharmaceuticals Inc | Método para tratar uma doença do fígado, para diminuir um nível elevado de uma enzima do fígado, para inibir uma cascata de sinalização de tnf-alfa e uma cascata de sinalização de alfa-faz, para reduzir um dano ao fígado, para suprimir a apoptose excessiva em uma célula de fígado, e para inibir a replicação do vírus da hepatite c. |
| ES2693948T3 (es) | 2007-03-15 | 2018-12-14 | Auspex Pharmaceuticals, Inc. | Fenetilamina sustituida con actividad serotoninérgica y/o norepinefrinérgica |
| US7892776B2 (en) | 2007-05-04 | 2011-02-22 | The Regents Of The University Of California | Screening assay to identify modulators of protein kinase A |
| MX2010000465A (es) * | 2007-07-12 | 2010-08-30 | Tragara Pharmaceuticals Inc | Metodos y composiciones para el tratamiento de cancer, tumores y alteraciones relacionadas con tumores. |
| CN101855228B (zh) * | 2007-09-11 | 2012-10-24 | 杏林制药株式会社 | 作为gsk-3抑制剂的氰基氨基喹诺酮和四唑并氨基喹诺酮 |
| US8476261B2 (en) | 2007-09-12 | 2013-07-02 | Kyorin Pharmaceutical Co., Ltd. | Spirocyclic aminoquinolones as GSK-3 inhibitors |
| US20090264421A1 (en) * | 2007-10-05 | 2009-10-22 | Bible Keith C | Methods and Compositions for Treating Cancer |
| AU2008324609B2 (en) * | 2007-11-07 | 2015-04-23 | Wai Lun Ho | Tunable vibration absorbing device |
| CA2706465A1 (en) | 2007-11-21 | 2009-05-28 | Pharmaxis Ltd. | Haloallylamine inhibitors of ssao/vap-1 and uses therefor |
| WO2009111611A2 (en) * | 2008-03-05 | 2009-09-11 | Proteotech Inc. | Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes |
| PL2947072T3 (pl) | 2008-03-17 | 2017-05-31 | Ambit Biosciences Corporation | 1-(3-(6,7-dimetoksychinazolin-4-yloksy)fenylo)-3-(5-(1,1,1-trifluoro-2-metylopropan-2-ylo)izoksazol-3-ilo)mocznik jako modulator kinazy RAF w leczeniu chorób nowotworowych |
| US20120034155A1 (en) * | 2010-08-03 | 2012-02-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Artificial cells |
| CN101658533A (zh) * | 2008-08-29 | 2010-03-03 | 首都医科大学宣武医院 | 抗肿瘤药物的干细胞递送 |
| US8048204B2 (en) | 2008-09-23 | 2011-11-01 | Rwdi Air Inc. | Wall assembly |
| WO2010088450A2 (en) | 2009-01-30 | 2010-08-05 | Celladon Corporation | Methods for treating diseases associated with the modulation of serca |
| US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
| PL2401267T3 (pl) * | 2009-02-27 | 2014-06-30 | Ambit Biosciences Corp | Pochodne chinazoliny modulujące kinazę JAK i ich zastosowanie w metodach |
| JP5690286B2 (ja) | 2009-03-04 | 2015-03-25 | イデニク プハルマセウティカルス,インコーポレイテッド | ホスホチオフェン及びホスホチアゾールhcvポリメラーゼ阻害剤 |
| KR101748891B1 (ko) * | 2009-03-11 | 2017-06-19 | 교린 세이야꾸 가부시키 가이샤 | Gsk-3 억제제로서의 7-시클로알킬아미노퀴놀론 |
| JP2012520314A (ja) | 2009-03-11 | 2012-09-06 | アムビト ビオスシエンセス コルポラチオン | 癌治療のためのインダゾリルアミノピロロトリアジンとタキサンの併用 |
| US8146310B2 (en) * | 2009-03-11 | 2012-04-03 | Keene Building Products Co., Inc. | Noise control flooring system |
| WO2010110686A1 (en) | 2009-03-27 | 2010-09-30 | Pathway Therapeutics Limited | Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy |
| AU2010229468A1 (en) | 2009-03-27 | 2011-10-13 | Vetdc, Inc. | Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| AR076363A1 (es) | 2009-04-22 | 2011-06-08 | Axikin Pharmaceuticals Inc | Antagonistas de ccr3 de arilsulfonamida |
| SG175748A1 (en) | 2009-04-22 | 2011-12-29 | Axikin Pharmaceuticals Inc | 2,5-disubstituted arylsulfonamide ccr3 antagonists |
| PE20120810A1 (es) | 2009-04-22 | 2012-07-08 | Axikin Pharmaceuticals Inc | Compuestos derivados de 5-ciano-2-(feniltio)bencensulfonamida como antagonistas de ccr3 |
| WO2011003870A2 (en) | 2009-07-06 | 2011-01-13 | Creabilis S.A. | Mini-pegylated corticosteroids, compositions including same, and methods of making and using same |
| US8486939B2 (en) | 2009-07-07 | 2013-07-16 | Pathway Therapeutics Inc. | Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| ES2655883T5 (es) | 2009-07-08 | 2022-04-18 | Hope Medical Entpr Inc D B A Hope Pharmaceuticals | Composiciones farmacéuticas que contienen tiosulfato de sodio |
| US8404728B2 (en) | 2009-07-30 | 2013-03-26 | Mayo Foundation For Medical Education And Research | Small-molecule botulinum toxin inhibitors |
| US9284307B2 (en) | 2009-08-05 | 2016-03-15 | Idenix Pharmaceuticals Llc | Macrocyclic serine protease inhibitors |
| BR112012003661A2 (pt) | 2009-08-19 | 2017-04-25 | Ambit Biosciences Corp | "compostos de biarila e métodos de uso dos mesmos." |
| NL2003697C2 (nl) | 2009-10-22 | 2011-04-26 | Univ Twente | Weg met geluid-diffractoren. |
| TW201120037A (en) | 2009-10-26 | 2011-06-16 | Sunesis Pharmaceuticals Inc | Compounds and methods for treatment of cancer |
| WO2011056764A1 (en) | 2009-11-05 | 2011-05-12 | Ambit Biosciences Corp. | Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles |
| WO2011057214A2 (en) | 2009-11-09 | 2011-05-12 | Neurogenetic Pharmaceuticals, Inc. | Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor |
| US8528286B2 (en) * | 2009-11-10 | 2013-09-10 | Keene Building Products Co., Inc. | Sound control mat |
| US20110301235A1 (en) | 2009-12-02 | 2011-12-08 | Alquest Therapeutics, Inc. | Organoselenium compounds and uses thereof |
| SG181797A1 (en) | 2009-12-18 | 2012-07-30 | Idenix Pharmaceuticals Inc | 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
| EP2515654A4 (de) * | 2009-12-23 | 2013-04-24 | Map Pharmaceuticals Inc | Neue ergolinanaloga |
| WO2011094890A1 (en) | 2010-02-02 | 2011-08-11 | Argusina Inc. | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| EP2542542B1 (de) | 2010-03-02 | 2015-04-22 | Axikin Pharmaceuticals, Inc. | Isotopisch angereicherte arylsulfonamid-ccr3-antagonisten |
| WO2011112689A2 (en) | 2010-03-11 | 2011-09-15 | Ambit Biosciences Corp. | Saltz of an indazolylpyrrolotriazine |
| WO2011116161A2 (en) | 2010-03-17 | 2011-09-22 | Axikin Pharmaceuticals Inc. | Arylsulfonamide ccr3 antagonists |
| WO2011150201A2 (en) | 2010-05-27 | 2011-12-01 | Ambit Biosciences Corporation | Azolyl amide compounds and methods of use thereof |
| WO2011150198A1 (en) | 2010-05-27 | 2011-12-01 | Ambit Biosciences Corporation | Azolyl urea compounds and methods of use thereof |
| WO2011153197A1 (en) | 2010-06-01 | 2011-12-08 | Biotheryx, Inc. | Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases |
| CA2801003A1 (en) | 2010-06-01 | 2011-12-08 | Biotheryx, Inc. | Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridone |
| NZ604018A (en) | 2010-06-07 | 2015-02-27 | Novomedix Llc | Furanyl compounds and the use thereof |
| MX347927B (es) | 2010-07-19 | 2017-05-19 | Summa Health System | Vitamina c y vitamina k libre de cromo, y composiciones de estas para tratar un estado o enfermedad en las que interviene nfkb. |
| US20140200270A1 (en) | 2013-01-11 | 2014-07-17 | Summa Health System | Vitamins c and k for treating polycystic diseases |
| WO2012030914A1 (en) | 2010-09-01 | 2012-03-08 | Ambit Boisciences Corporation | 4-azolylaminoquinazoline derivatives and methods of use thereof |
| US20130303533A1 (en) | 2010-09-01 | 2013-11-14 | Ambit Biosciences Corporation | Azolopyridine and azolopyrimidine compounds and methods of use thereof |
| WO2012030910A1 (en) | 2010-09-01 | 2012-03-08 | Ambit Biosciences Corporation | 2-cycloquinazoline derivatives and methods of use thereof |
| US20130296363A1 (en) | 2010-09-01 | 2013-11-07 | Ambit Biosciences Corporation | Quinoline and isoquinoline derivatives for use as jak modulators |
| EP2611812A1 (de) | 2010-09-01 | 2013-07-10 | Ambit Biosciences Corporation | Thienopyridin- und thienopyrimidinverbindungen sowie verfahren zu ihrer verwendung |
| US8912324B2 (en) | 2010-09-01 | 2014-12-16 | Ambit Biosciences Corporation | Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof |
| EP2611792B1 (de) | 2010-09-01 | 2017-02-01 | Ambit Biosciences Corporation | Hydrobromid salze einer pyrazolylaminoquinazolin |
| EP2611502A1 (de) | 2010-09-01 | 2013-07-10 | Ambit Biosciences Corporation | Adenosin-a3-rezeptormodulierende verbindungen und ihre verwendung |
| AU2011296024B2 (en) | 2010-09-01 | 2015-05-28 | Ambit Biosciences Corporation | Quinazoline compounds and methods of use thereof |
| WO2012030912A1 (en) | 2010-09-01 | 2012-03-08 | Ambit Biosciences Corporation | 7-cyclylquinazoline derivatives and methods of use thereof |
| WO2012044641A1 (en) | 2010-09-29 | 2012-04-05 | Pathway Therapeutics Inc. | 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| US20120088769A1 (en) | 2010-10-11 | 2012-04-12 | Axikin Pharmaceuticals, Inc. | Salts of arylsulfonamide ccr3 antagonists |
| US20120125711A1 (en) * | 2010-11-24 | 2012-05-24 | Stahr Richard E | Sound absorbing panel and system |
| WO2012078649A1 (en) | 2010-12-06 | 2012-06-14 | Follica, Inc. | Methods for treating baldness and promoting hair growth |
| WO2012080050A1 (en) | 2010-12-14 | 2012-06-21 | F. Hoffmann-La Roche Ag | Solid forms of a phenoxybenzenesulfonyl compound |
| EP3763740A1 (de) | 2011-01-26 | 2021-01-13 | Celldex Therapeutics, Inc. | Anti-kit-antikörper und verwendungen davon |
| JP2014503597A (ja) | 2011-01-31 | 2014-02-13 | セルジーン コーポレイション | シチジンアナログの医薬組成物及びその使用方法 |
| US9353100B2 (en) | 2011-02-10 | 2016-05-31 | Idenix Pharmaceuticals Llc | Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections |
| AU2012236722A1 (en) | 2011-03-28 | 2013-10-17 | Mei Pharma, Inc. | (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases |
| US20140088103A1 (en) | 2011-03-28 | 2014-03-27 | Mei Pharma, Inc. | (fused ring arylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases |
| EP2691384B1 (de) | 2011-03-28 | 2016-10-26 | MEI Pharma, Inc. | (alpha-substituierte aralkylamino- und heteroaralkylamino)-pyrimidinyl- und 1,3,5-triazinyl-benzimidazoles, sie enthaltende pharmazeutische zusammensetzungen und diese verbindungen zur verwendung bei der behandlung proliferativer erkrankungen |
| US20120252721A1 (en) | 2011-03-31 | 2012-10-04 | Idenix Pharmaceuticals, Inc. | Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor |
| EP2723735A4 (de) | 2011-06-23 | 2015-02-18 | Map Pharmaceuticals Inc | Neue fluorergolin-analoga |
| WO2013037482A1 (en) | 2011-09-15 | 2013-03-21 | Phenex Pharmaceuticals Ag | Farnesoid x receptor agonists for cancer treatment and prevention |
| MY167575A (en) | 2011-10-14 | 2018-09-20 | Ambit Biosciences Corp | Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases |
| AU2012355982A1 (en) | 2011-12-19 | 2014-07-10 | Map Pharmaceuticals, Inc. | Novel iso-ergoline derivatives |
| US8946420B2 (en) | 2011-12-21 | 2015-02-03 | Map Pharmaceuticals, Inc. | Neuromodulatory compounds |
| WO2013130600A1 (en) | 2012-02-29 | 2013-09-06 | Ambit Biosciences Corporation | Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith |
| TW201341367A (zh) | 2012-03-16 | 2013-10-16 | Axikin Pharmaceuticals Inc | 3,5-二胺基吡唑激酶抑制劑 |
| SI2844637T1 (en) | 2012-05-02 | 2018-07-31 | Boehringer Ingelheim International Gmbh | Substituted 3-haloallylamine inhibitors of ssao and uses thereof |
| US9732038B2 (en) | 2012-06-14 | 2017-08-15 | Mayo Foundation For Medical Education And Research | Pyrazole derivatives as inhibitors of STAT3 |
| US9012640B2 (en) | 2012-06-22 | 2015-04-21 | Map Pharmaceuticals, Inc. | Cabergoline derivatives |
| CN104812775B (zh) | 2012-07-25 | 2019-05-03 | 塞尔德克斯医疗公司 | 抗kit抗体及其用途 |
| US9074186B2 (en) | 2012-08-15 | 2015-07-07 | Boston Medical Center Corporation | Production of red blood cells and platelets from stem cells |
| US9156799B2 (en) | 2012-09-07 | 2015-10-13 | Axikin Pharmaceuticals, Inc. | Isotopically enriched arylsulfonamide CCR3 antagonists |
| WO2014055647A1 (en) | 2012-10-03 | 2014-04-10 | Mei Pharma, Inc. | (sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases |
| US20150272924A1 (en) | 2012-11-08 | 2015-10-01 | Summa Health System | Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing |
| AU2013352106B2 (en) | 2012-11-30 | 2018-04-26 | Novomedix, Llc | Substituted biaryl sulfonamides and the use thereof |
| CA2895829A1 (en) | 2012-12-21 | 2014-06-26 | Map Pharmaceuticals, Inc. | Novel methysergide derivatives |
| US9169214B2 (en) | 2012-12-21 | 2015-10-27 | The Board Of Trustees Of The Leland Stanford Junior University | Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions |
| SG10201708143QA (en) | 2013-06-06 | 2017-11-29 | Pf Medicament | Anti-c10orf54 antibodies and uses thereof |
| WO2015005774A1 (en) * | 2013-07-07 | 2015-01-15 | 4Silence B.V. | Diffractor for diffracting sound |
| CN105683182A (zh) | 2013-08-30 | 2016-06-15 | 埃姆比特生物科学公司 | 联芳基乙酰胺化合物及其使用方法 |
| NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
| WO2015042375A1 (en) | 2013-09-20 | 2015-03-26 | Idenix Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
| EP3450571B1 (de) | 2014-02-24 | 2023-04-05 | Celgene Corporation | Verfahren zur verwendung eines aktivators von cereblon für neuronale zellexpansion und behandlung von erkrankungen des zentralnervensystems |
| GB201403775D0 (en) | 2014-03-04 | 2014-04-16 | Kymab Ltd | Antibodies, uses & methods |
| US20170066779A1 (en) | 2014-03-05 | 2017-03-09 | Idenix Pharmaceuticals Llc | Solid forms of a flaviviridae virus inhibitor compound and salts thereof |
| TWI705967B (zh) | 2014-03-20 | 2020-10-01 | 美商卡佩拉醫療公司 | 苯并咪唑衍生物及其醫藥組合物及使用方法 |
| CA3175724C (en) | 2014-03-20 | 2024-01-09 | Capella Therapeutics, Inc. | Benzimidazole derivatives, and pharmaceutical compositions and methods of use thereof |
| EP3142649B1 (de) | 2014-05-12 | 2019-07-24 | Conatus Pharmaceuticals, Inc. | Behandlung der komplikationen von chronischer lebererkrankung mit caspase-inhibitor emricasan |
| DK3148579T3 (da) | 2014-05-28 | 2021-03-08 | Agenus Inc | Anti-gitr antistoffer og fremgangsmåder til anvendelse deraf |
| US9527815B2 (en) | 2014-06-18 | 2016-12-27 | Biotheryx, Inc. | Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases |
| US9499514B2 (en) | 2014-07-11 | 2016-11-22 | Celgene Corporation | Antiproliferative compounds and methods of use thereof |
| US20160045609A1 (en) | 2014-08-14 | 2016-02-18 | Mamoun M. Alhamadsheh | Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life |
| JP2017526713A (ja) | 2014-09-12 | 2017-09-14 | トビラ セラピューティクス, インコーポレイテッド | 線維症を処置するためのセニクリビロック併用療法 |
| EP3209658A1 (de) | 2014-10-24 | 2017-08-30 | Biogen MA Inc. | Diterpenoidderivate und verfahren zur verwendung |
| EP3789039A1 (de) | 2014-12-22 | 2021-03-10 | The Rockefeller University | Anti-mertk-antikörper und verwendungen davon |
| HUE049801T2 (hu) | 2014-12-23 | 2020-10-28 | Sma Therapeutics Inc | 3,5-diaminopirazol kináz inhibitorok |
| CN113149982A (zh) | 2015-01-20 | 2021-07-23 | Xoc制药股份有限公司 | 麦角灵化合物及其用途 |
| CN107428749B (zh) | 2015-01-28 | 2020-07-24 | 上海复旦张江生物医药股份有限公司 | 取代的咪唑并[1,2-α]吡啶-2-基胺化合物及其药物组合物和使用方法 |
| KR102740384B1 (ko) | 2015-03-03 | 2024-12-06 | 키맵 리미티드 | 항체, 용도 및 방법 |
| CA2986765A1 (en) | 2015-05-29 | 2016-12-08 | Agenus Inc. | Anti-ctla-4 antibodies and methods of use thereof |
| WO2016210180A2 (en) | 2015-06-23 | 2016-12-29 | Neurocrine Biosciences, Inc. | Vmat2 inhibitors for treating neurological diseases or disorders |
| EP3344656A1 (de) | 2015-09-01 | 2018-07-11 | Agenus Inc. | Anti-pd-1-antikörper und verfahren zur verwendung davon |
| IL284874B2 (en) | 2015-10-30 | 2023-10-01 | Neurocrine Biosciences Inc | Valbenazine salts and polymorphs thereof |
| WO2017079566A1 (en) | 2015-11-05 | 2017-05-11 | Conatus Pharmaceuticals, Inc. | Caspase inhibitors for use in the treatment of liver cancer |
| US10112924B2 (en) | 2015-12-02 | 2018-10-30 | Astraea Therapeutics, Inc. | Piperdinyl nociceptin receptor compounds |
| EP4455145A3 (de) | 2015-12-02 | 2025-03-12 | Astraea Therapeutics, LLC | Piperidinyl-nociceptin-rezeptorverbindungen |
| LT3394057T (lt) | 2015-12-23 | 2022-06-27 | Neurocrine Biosciences, Inc. | Sintezės būdas, skirtas pagaminti (s)-(2r,3r,11br)-3-izobutil-9,10-dimetoksi-2,3,4,6,7,11b-heksahidro-1h-pirido[2,1-a]izochinolin-2-ilo 2-amino-3-metilbutanoato di(4-metilbenzensulfonatą) |
| EP3397251A1 (de) | 2015-12-31 | 2018-11-07 | Conatus Pharmaceuticals, Inc. | Verfahren zur verwendung von caspase-hemmern bei der behandlung von lebererkrankungen |
| MX385964B (es) | 2016-01-08 | 2025-03-18 | Celgene Corp | Formas sólidas de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolin-5-il) metil)-2,2-difluoroacetamida y sus composiciones farmacéuticas y usos. |
| EP3399978B1 (de) | 2016-01-08 | 2020-09-09 | Celgene Corporation | Antiproliferative verbindungen und deren pharmazeutische zusammensetzungen und verwendungen |
| US10960013B2 (en) | 2016-03-04 | 2021-03-30 | East Carolina University | J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders |
| US10064855B2 (en) | 2016-03-08 | 2018-09-04 | Los Gatos Pharmaceuticals, Inc. | Composite nanoparticles and uses thereof |
| WO2017156183A1 (en) | 2016-03-08 | 2017-09-14 | Los Gatos Pharmaceuticals, Inc. | Camptothecin derivatives and uses thereof |
| WO2017180589A1 (en) | 2016-04-11 | 2017-10-19 | Auspex Pharmaceuticals, Inc. | Deuterated ketamine derivatives |
| EP4190357A1 (de) | 2016-05-13 | 2023-06-07 | Institut Pasteur | Hemmung von beta-2-nikotin-acetylcholinrezeptoren zur behandlung von morbus-alzheimer-pathologie |
| TWI753910B (zh) | 2016-05-16 | 2022-02-01 | 美商拜歐斯瑞克斯公司 | 吡啶硫酮、其醫藥組合物及其治療增生性、炎性、神經退化性或免疫介導疾病之治療用途 |
| MX389710B (es) | 2016-05-27 | 2025-03-20 | Agenus Inc | Anticuerpos anti proteina inmunoglobulina de linfocitos t y dominio de mucina 3 (tim-3) y métodos para usarlos. |
| DE102016111064A1 (de) * | 2016-06-16 | 2017-12-21 | Vossloh-Werke Gmbh | Elastisches Element für einen Befestigungspunkt für eine Schiene für Schienenfahrzeuge und Befestigungspunkt |
| CN106087611B (zh) * | 2016-06-20 | 2019-07-12 | 勾厚渝 | 轨道交通构件 |
| EP3481864A1 (de) | 2016-07-08 | 2019-05-15 | Staten Biotechnology B.V. | Anti-apoc3-antikörper und verfahren zur verwendung davon |
| US10919904B2 (en) | 2016-08-17 | 2021-02-16 | North Carolina State University | Northern-southern route to synthesis of bacteriochlorins |
| MX390121B (es) | 2016-09-19 | 2025-03-20 | Mei Pharma Inc | Combinaciones de un inhibidor de btk y un inhibidor de pi3k para tratar neoplasias malignas hematológicas. |
| KR102576042B1 (ko) | 2016-10-11 | 2023-09-07 | 아게누스 인코포레이티드 | 항-lag-3 항체 및 이의 사용 방법 |
| US11779604B2 (en) | 2016-11-03 | 2023-10-10 | Kymab Limited | Antibodies, combinations comprising antibodies, biomarkers, uses and methods |
| KR102431830B1 (ko) | 2016-11-07 | 2022-08-16 | 주식회사 뉴라클사이언스 | 서열 유사성을 가진 항-패밀리 19, 멤버 a5 항체 및 그것의 사용 방법 |
| WO2018089692A1 (en) | 2016-11-09 | 2018-05-17 | Phloronol, Inc. | Eckol derivatives, methods of synthesis and uses thereof |
| WO2018089427A1 (en) | 2016-11-09 | 2018-05-17 | Novomedix, Llc | Nitrite salts of 1, 1-dimethylbiguanide, pharmaceutical compositions, and methods of use |
| WO2018102252A1 (en) | 2016-11-30 | 2018-06-07 | North Carolina State University | Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds |
| JP7105774B2 (ja) | 2016-12-01 | 2022-07-25 | イグナイタ インコーポレイテッド | がん治療のための方法 |
| TW202345829A (zh) | 2016-12-02 | 2023-12-01 | 美商紐羅克里生物科學有限公司 | 戊苯那嗪(valbenazine)於治療精神分裂症或情感性精神分裂症之用途 |
| CN118634323A (zh) | 2016-12-07 | 2024-09-13 | 艾吉纳斯公司 | 抗体和其使用方法 |
| FI3551660T3 (fi) | 2016-12-07 | 2023-12-11 | Agenus Inc | Anti-ctla-4-vasta-aineita ja niiden käyttömenetelmiä |
| KR20230169457A (ko) | 2017-01-27 | 2023-12-15 | 뉴로크린 바이오사이언시즈 인코퍼레이티드 | 특정 vmat2 억제제의 투여 방법 |
| AU2018220515B2 (en) | 2017-02-17 | 2022-06-30 | DayLife LLC | Universal antivenom |
| CN116730920A (zh) | 2017-02-17 | 2023-09-12 | 文涵治疗有限公司 | Ag-10的制备方法、其中间体及其盐 |
| WO2018164996A1 (en) | 2017-03-06 | 2018-09-13 | Neurocrine Biosciences, Inc. | Dosing regimen for valbenazine |
| KR20190133198A (ko) | 2017-03-27 | 2019-12-02 | 셀진 코포레이션 | 면역원성의 감소를 위한 방법 및 조성물 |
| JP7297672B2 (ja) | 2017-04-13 | 2023-06-26 | アジェナス インコーポレイテッド | 抗cd137抗体およびその使用方法 |
| CA3059133A1 (en) | 2017-04-21 | 2018-10-25 | Staten Biotechnology B.V. | Anti-apoc3 antibodies and methods of use thereof |
| US20200179352A1 (en) | 2017-04-26 | 2020-06-11 | Neurocrine Biosciences, Inc. | Use of valbenazine for treating levodopa-induced dyskinesia |
| RS64576B1 (sr) | 2017-05-01 | 2023-10-31 | Agenus Inc | Anti-tigit antitela i postupci njihove primene |
| JOP20190219A1 (ar) | 2017-05-09 | 2019-09-22 | Cardix Therapeutics LLC | تركيبات صيدلانية وطرق لعلاج أمراض القلب والأوعية الدموية |
| US10085999B1 (en) | 2017-05-10 | 2018-10-02 | Arixa Pharmaceuticals, Inc. | Beta-lactamase inhibitors and uses thereof |
| CA3067416A1 (en) | 2017-06-27 | 2019-01-03 | Neuracle Science Co., Ltd. | Use of anti-fam19a5 antibodies for treating cancers |
| CN111344011B (zh) | 2017-06-27 | 2024-01-26 | 纽洛可科学有限公司 | 抗fam19a5抗体用于治疗纤维化的用途 |
| JP7076059B2 (ja) | 2017-06-27 | 2022-05-27 | ニューラクル サイエンス カンパニー リミテッド | 抗fam19a5抗体及びその用途 |
| JP6904616B2 (ja) | 2017-06-27 | 2021-07-21 | ニューラクル サイエンス カンパニー リミテッド | 緑内障治療のための配列相同性を有するファミリー、メンバーa5抗体の用途 |
| ES2953032T3 (es) | 2017-09-01 | 2023-11-07 | Univ East Carolina | Métodos ex vivo para la activación de las células inmunológicas |
| RS66714B1 (sr) | 2017-09-21 | 2025-05-30 | Neurocrine Biosciences Inc | Formulacija visoke doze valbenazina i sastavi, postupci i kompleti povezani sa njim |
| CN111263820B (zh) | 2017-10-02 | 2024-07-02 | 纽洛可科学有限公司 | 抗序列相似家族19成员a5抗体用于治疗和诊断情绪障碍的用途 |
| CA3076920A1 (en) | 2017-10-04 | 2019-04-11 | The Regents Of The University Of California | Immunomodulatory oligosaccharides |
| MX2020003421A (es) | 2017-10-10 | 2020-07-20 | Neurocrine Biosciences Inc | Metodos para la administracion de ciertos inhibidores del transportador vesicular de monoamina 2 (vmat2). |
| KR20250070134A (ko) | 2017-10-10 | 2025-05-20 | 뉴로크린 바이오사이언시즈 인코퍼레이티드 | 특정 vmat2 억제제의 투여 방법 |
| CA3080103A1 (en) | 2017-10-31 | 2019-05-09 | Staten Biotechnology B.V. | Anti-apoc3 antibodies and methods of use thereof |
| WO2019139871A1 (en) | 2018-01-10 | 2019-07-18 | Cura Therapeutics Llc | Pharmaceutical compositions comprising dicarboxylic acids and their therapeutic applications |
| AU2019207491A1 (en) | 2018-01-10 | 2020-07-30 | Cura Therapeutics, Llc | Pharmaceutical compositions comprising phenylsulfonamides, and their therapeutic applications |
| MA52137A (fr) | 2018-03-23 | 2021-01-27 | Eidos Therapeutics Inc | Méthodes de traitement de l'amylose ttr à l'aide d'ag10 |
| AU2019259798A1 (en) | 2018-04-24 | 2020-11-12 | Neuracle Science Co., Ltd. | Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of neuropathic pain |
| KR20240056644A (ko) | 2018-05-10 | 2024-04-30 | 주식회사 뉴라클사이언스 | 서열 유사성 19, 멤버 a5 항체를 갖는 항-패밀리 및 그의 사용 방법 |
| EP3806856A1 (de) | 2018-06-14 | 2021-04-21 | Neurocrine Biosciences, Inc. | Vmat2-inhibitorverbindungen, zusammensetzungen und verfahren im zusammenhang damit |
| CN108836091B (zh) * | 2018-06-27 | 2020-12-04 | 贵州筑信达创科技有限公司 | 导轨 |
| CN108533609B (zh) * | 2018-06-27 | 2020-03-10 | 贵州筑信达创科技有限公司 | 导轨及滑动件的组合结构 |
| EP3814327A1 (de) | 2018-06-29 | 2021-05-05 | Histogen, Inc. | (s)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorphenoxy)pentansäure-derivate und verwandte verbindungen als caspase-inhibitoren zur behandlung kardiovaskulärer erkrankungen |
| IL280199B2 (en) | 2018-07-20 | 2025-08-01 | Pf Medicament | Receptor for vista |
| MA53239A (fr) | 2018-08-15 | 2022-05-04 | Neurocrine Biosciences Inc | Procédés d'administration de certains inhibiteurs de vmat2 |
| AU2019321583C1 (en) | 2018-08-17 | 2025-11-27 | Eidos Therapeutics, Inc. | Formulations of AG10 |
| AU2019352017A1 (en) | 2018-10-03 | 2021-05-06 | Staten Biotechnology B.V. | Antibodies specific for human and cynomolgus ApoC3 and methods of use thereof |
| AU2019363368A1 (en) | 2018-10-16 | 2021-05-13 | Neuracle Science Co., Ltd. | Use of anti-FAM19A5 antibodies |
| CN113365650A (zh) | 2018-11-16 | 2021-09-07 | 新免疫技术有限公司 | 用il-7蛋白和免疫检查点抑制剂的组合治疗肿瘤的方法 |
| WO2020118042A1 (en) | 2018-12-05 | 2020-06-11 | Jacobs Wagner Christine | Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of lyme disease-related pathologies |
| KR20200071198A (ko) | 2018-12-10 | 2020-06-19 | 네오이뮨텍, 인코퍼레이티드 | Nrf2 발현 조절 기반 T 세포 항암면역치료법 |
| EP3898609A1 (de) | 2018-12-19 | 2021-10-27 | Shy Therapeutics LLC | Mit der ras-superfamilie interagierende verbindungen zur behandlung von krebs, entzündlichen erkrankungen, rasopathien und fibrotischen erkrankungen |
| JP7239216B2 (ja) | 2018-12-27 | 2023-03-14 | ニューラクル サイエンス カンパニー リミテッド | 粥状硬化症を治療するための抗fam19a5抗体の使用 |
| CN113195533B (zh) | 2019-01-02 | 2024-04-26 | 纽洛可科学有限公司 | 抗序列相似家族19成员a5的抗体及其使用方法 |
| TWI839461B (zh) | 2019-02-06 | 2024-04-21 | 美商戴斯阿爾法股份有限公司 | Il-17a調節物及其用途 |
| ES2978570T3 (es) | 2019-02-26 | 2024-09-16 | Inspirna Inc | Anticuerpos anti-MERTK de alta afinidad y sus usos |
| WO2020181165A1 (en) | 2019-03-07 | 2020-09-10 | Conatus Pharmaceuticals Inc. | Caspase inhibitors and methods of use thereof |
| CN114222802B (zh) | 2019-05-20 | 2025-07-11 | 尼尔瓦纳科学股份有限公司 | 窄发射染料、包含其的组合物以及制备和使用其的方法 |
| JP7754724B2 (ja) | 2019-05-20 | 2025-10-15 | ニルバナ サイエンシーズ インク. | 発光波長の範囲が狭い発光染料、それを含む組成物及びそれを製造及び使用する方法 |
| AU2020311404A1 (en) | 2019-07-11 | 2022-03-03 | Cura Therapeutics, Llc | Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications for the treatment of neurodegenerative diseases |
| AU2020310190A1 (en) | 2019-07-11 | 2022-02-24 | Cura Therapeutics, Llc | Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications |
| US10940141B1 (en) | 2019-08-23 | 2021-03-09 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| KR20220053007A (ko) | 2019-08-30 | 2022-04-28 | 아게누스 인코포레이티드 | 항-cd96 항체 및 이의 사용 방법 |
| JP7566889B2 (ja) | 2019-09-16 | 2024-10-15 | ダイス・アルファ・インコーポレイテッド | Il-17aモジュレーターおよびその使用 |
| KR102337657B1 (ko) * | 2019-11-06 | 2021-12-09 | 한국철도기술연구원 | 철도진동저감용 조립식 블록 및 이를 이용한 블록 구조물 |
| US20230057939A1 (en) | 2020-01-13 | 2023-02-23 | Neoimmunetech, Inc. | Method of treating a tumor with a combination of il-7 protein and a bispecific antibody |
| CN113136745B (zh) * | 2020-01-17 | 2024-10-25 | 洛阳双瑞橡塑科技有限公司 | 一种轨道道床吸音减振装置 |
| WO2021151001A1 (en) | 2020-01-22 | 2021-07-29 | Outpace Bio, Inc. | Chimeric polypeptides |
| US20230210952A1 (en) | 2020-02-05 | 2023-07-06 | Washington University | Method of treating a solid tumor with a combination of an il-7 protein and car-bearing immune cells |
| US12006643B2 (en) * | 2020-05-27 | 2024-06-11 | Mute Wall Systems, Inc. | Sound dampening barrier wall |
| EP4157271A1 (de) | 2020-05-29 | 2023-04-05 | Boulder Bioscience LLC | Verfahren zur verbesserten endovaskulären thrombektomie mit 3,3'-diindolylmethan |
| WO2021257828A1 (en) | 2020-06-18 | 2021-12-23 | Shy Therapeutics, Llc | Substituted thienopyrimidines that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
| EP4149471A4 (de) | 2020-06-30 | 2024-07-10 | Prosetta Biosciences, Inc. | Isochinolinderivate, verfahren zur synthese und verwendungen davon |
| WO2022061348A1 (en) | 2020-09-16 | 2022-03-24 | Biotheryx, Inc. | Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications |
| TW202231269A (zh) | 2020-10-23 | 2022-08-16 | 美商拜歐斯瑞克斯公司 | Kras蛋白降解劑、其醫藥組合物及其治療應用 |
| US20240101629A1 (en) | 2020-11-02 | 2024-03-28 | Neoimmunetech, Inc. | Use of interleukin-7 for the treatment of coronavirus |
| CN116615236A (zh) | 2020-11-05 | 2023-08-18 | 新免疫技术有限公司 | 用il-7蛋白和核苷酸疫苗的组合治疗肿瘤的方法 |
| CN112712784B (zh) * | 2020-11-30 | 2024-12-31 | 南京华秦光声科技有限责任公司 | 一种低频宽带平板吸声结构 |
| AU2021402911A1 (en) | 2020-12-14 | 2023-07-06 | Biotheryx, Inc. | Pde4 degraders, pharmaceutical compositions, and therapeutic applications |
| US20240124483A1 (en) | 2021-01-27 | 2024-04-18 | Shy Therapeutics, Llc | Methods for the Treatment of Fibrotic Disease |
| US20240309015A1 (en) | 2021-01-27 | 2024-09-19 | Shy Therapeutics, Llc | Methods for the Treatment of Fibrotic Disease |
| IL305752A (en) | 2021-03-10 | 2023-11-01 | Dice Molecules Sv Inc | INTEGRIN INHIBITORS OF ALPHA V BETA 6 AND ALPHA V BETA 1 AND THEIR USES |
| WO2022226166A1 (en) | 2021-04-22 | 2022-10-27 | Protego Biopharma, Inc. | Spirocyclic imidazolidinones and imidazolidinediones for treatment of light chain amyloidosis |
| EP4347568A1 (de) | 2021-05-27 | 2024-04-10 | Protego Biopharma, Inc. | Heteroaryldiamid-ire1/xbp1s-aktivatoren |
| WO2022251644A1 (en) | 2021-05-28 | 2022-12-01 | Lyell Immunopharma, Inc. | Nr4a3-deficient immune cells and uses thereof |
| JP2024520676A (ja) | 2021-06-02 | 2024-05-24 | ライエル・イミュノファーマ・インコーポレイテッド | Nr4a3欠損免疫細胞及びその使用 |
| CA3218481A1 (en) | 2021-06-14 | 2022-12-22 | argenx BV | Anti-il-9 antibodies and methods of use thereof |
| WO2022266249A1 (en) | 2021-06-16 | 2022-12-22 | Biotheryx, Inc. | Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications |
| JP2024522768A (ja) | 2021-06-16 | 2024-06-21 | バイオセリックス, インコーポレイテッド | Sos1タンパク質分解剤、その医薬組成物及びそれらの治療的応用 |
| US20240277857A1 (en) | 2021-09-29 | 2024-08-22 | Nbios, Inc. | Coiled-coil fusion protein |
| AU2022368836A1 (en) | 2021-10-22 | 2024-05-02 | Prosetta Biosciences, Inc. | Novel host-targeted pan-respiratory antiviral small molecule therapeutics |
| KR20240115979A (ko) | 2021-11-08 | 2024-07-26 | 프로젠토스 테라퓨틱스, 인크. | 혈소판-유래 성장 인자 수용체(pdgfr) 알파 억제제 및 이의 용도 |
| EP4456907A1 (de) | 2021-12-30 | 2024-11-06 | NeoImmuneTech, Inc. | Verfahren zur behandlung eines tumors mit einer kombination aus il-7-protein und vegf-antagonist |
| WO2023129577A1 (en) | 2022-01-03 | 2023-07-06 | Lilac Therapeutics, Inc. | Cyclic thiol prodrugs |
| JP2025501308A (ja) | 2022-01-03 | 2025-01-17 | ライラック セラピューティクス, インク. | 非環式チオールプロドラッグ |
| WO2023157989A1 (ko) | 2022-02-17 | 2023-08-24 | 주식회사 노벨티노빌리티 | 항체-약물 접합체 |
| JP2025507621A (ja) | 2022-03-02 | 2025-03-21 | ミトパワー, インク. | ニコチン酸及びリボースから誘導体化した新規プロドラッグ |
| WO2023192904A1 (en) | 2022-03-30 | 2023-10-05 | Biomarin Pharmaceutical Inc. | Dystrophin exon skipping oligonucleotides |
| GB2619907A (en) | 2022-04-01 | 2023-12-27 | Kanna Health Ltd | Novel crystalline salt forms of mesembrine |
| AR129053A1 (es) | 2022-04-14 | 2024-07-10 | Bristol Myers Squibb Co | Nuevos compuestos gspt1 y métodos de uso de los nuevos compuestos |
| AU2023265665A1 (en) | 2022-05-05 | 2024-10-10 | Biomarin Pharmaceutical Inc. | Method of treating duchenne muscular dystrophy |
| IL316794A (en) | 2022-05-10 | 2025-01-01 | Biotheryx Inc | CDK protease inhibitors, pharmaceuticals and therapeutic applications |
| KR20250027283A (ko) | 2022-05-19 | 2025-02-25 | 라이엘 이뮤노파마, 인크. | nr4a3을 표적하는 폴리뉴클레오타이드 및 이의 용도 |
| JP2025531869A (ja) | 2022-09-09 | 2025-09-25 | イノヴォ セラピューティクス、インコーポレイテッド | CK1αおよびDUAL CK1α/GSPT1分解化合物 |
| EP4593826A1 (de) | 2022-09-30 | 2025-08-06 | Boulder Bioscience LLC | Zusammensetzungen mit 3,3'-diindolylmethan zur behandlung von nichthämorrhagischen verletzungen des geschlossenen kopfes |
| JP2025537484A (ja) | 2022-10-21 | 2025-11-18 | ダイアゴナル・セラピューティクス・インコーポレイテッド | Il-18受容体に対するヘテロマーアゴニスト抗体 |
| WO2024092040A1 (en) | 2022-10-26 | 2024-05-02 | Protego Biopharma, Inc. | Spirocycle containing bicyclic heteroaryl compounds |
| US20240174673A1 (en) | 2022-10-26 | 2024-05-30 | Protego Biopharma, Inc. | Spirocycle Containing Pyridine Compounds |
| EP4608838A1 (de) | 2022-10-26 | 2025-09-03 | Protego Biopharma, Inc. | Spirocyclus mit pyridonverbindungen |
| KR20250089492A (ko) | 2022-11-07 | 2025-06-18 | 네오이뮨텍, 인코퍼레이티드 | 비메틸화된 mgmt 프로모터를 갖는 종양의 치료 방법 |
| WO2024118810A1 (en) | 2022-11-30 | 2024-06-06 | Protego Biopharma, Inc. | Cyclic pyrazole diamide ire1/xbp1s activators |
| EP4626864A1 (de) | 2022-11-30 | 2025-10-08 | Protego Biopharma, Inc. | Lineare heteroaryldiamid-ire1/xbp1s-aktivatoren |
| KR102870410B1 (ko) * | 2022-12-09 | 2025-10-16 | 한국전자기술연구원 | 방음재 및 소음 제어 시스템 |
| WO2024194685A2 (en) | 2023-03-17 | 2024-09-26 | Oxitope Pharma B.V. | Anti-phosphocholine antibodies and methods of use thereof |
| AU2024240129A1 (en) | 2023-03-17 | 2025-10-09 | Oxitope Pharma B.V. | Anti-phosphocholine antibodies and methods of use thereof |
| EP4688147A1 (de) | 2023-04-07 | 2026-02-11 | Diagonal Therapeutics Inc. | Bispezifische agonistische antikörper gegen activin a rezeptor-ähnliches typ 1 (alk1) |
| AU2024254039A1 (en) | 2023-04-07 | 2025-10-02 | Diagonal Therapeutics Inc. | Hinge-modified bispecific antibodies |
| WO2024226471A2 (en) | 2023-04-24 | 2024-10-31 | Biomarin Pharmaceutical Inc. | Compositions and methods for treating stxbp1 disorders |
| TW202448485A (zh) | 2023-05-05 | 2024-12-16 | 美商拜奧馬林製藥公司 | 肌萎縮蛋白外顯子跳躍寡核苷酸 |
| EP4709725A1 (de) | 2023-05-09 | 2026-03-18 | Progentos Therapeutics, Inc. | Heterocyclische verbindungen und verwendungen davon |
| AU2024276812A1 (en) | 2023-05-19 | 2025-11-06 | Diagonal Therapeutics Inc. | Bispecific agonistic antibodies to il12 receptor |
| KR20260033048A (ko) | 2023-07-03 | 2026-03-10 | 네오이뮨텍, 인코퍼레이티드 | 이종이합체 fc 분자 및 이의 용도 |
| WO2025046298A2 (en) | 2023-09-01 | 2025-03-06 | iTeos Belgium SA | Anti-trem2 antibodies and methods of use |
| AU2024344247A1 (en) | 2023-09-19 | 2026-05-07 | Kancure Pte. Ltd. | Survivin-targeted compounds |
| IL327069A (en) | 2023-09-27 | 2026-05-01 | Isosterix Inc | Mist inhibitors |
| WO2025085416A1 (en) | 2023-10-16 | 2025-04-24 | Bristol-Myers Squibb Company | Gspt1 compounds and methods of use of the compounds |
| AU2024366926A1 (en) | 2023-10-23 | 2026-03-12 | Diagonal Therapeutics Inc. | Heteromeric agonistic antibodies to il-18 receptor |
| GB2636969A (en) | 2023-11-24 | 2025-07-09 | Ontrack Therapeutics Ltd | Novel crystalline salt forms |
| WO2025133707A1 (en) | 2023-12-19 | 2025-06-26 | Vectory Therapeutics B.V. | Anti-tdp-43 antibodies and uses thereof |
| WO2025147691A1 (en) | 2024-01-04 | 2025-07-10 | Innovo Therapeutics, Inc. | Compositions and methods for degrading aryl hydrocarbon receptor nuclear translocator protein |
| WO2025179161A1 (en) | 2024-02-21 | 2025-08-28 | Innovo Therapeutics, Inc. | Protein degrading compounds |
| WO2025201633A1 (en) | 2024-03-26 | 2025-10-02 | Chen Gefei | An agent for reducing amyloid formation |
| WO2025255341A1 (en) | 2024-06-05 | 2025-12-11 | Protego Biopharma, Inc. | Tetrahydrofuranyl ire1/xbp1s activators |
| WO2026080748A2 (en) | 2024-10-09 | 2026-04-16 | Diagonal Therapeutics Inc. | Bone morphogenetic protein receptor type 2 (bmprii) antibodies |
| WO2026080752A2 (en) | 2024-10-09 | 2026-04-16 | Diagonal Therapeutics Inc. | De novo antibodies to activin a receptor like type 1 (alk1) |
| WO2026080757A2 (en) | 2024-10-09 | 2026-04-16 | Diagonal Therapeutics Inc. | Activin receptor type ii a/b (actriia/b) antibodies |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3991848A (en) * | 1974-08-16 | 1976-11-16 | Frigitemp | Acoustical board |
| US4142468A (en) * | 1976-04-20 | 1979-03-06 | Charles Birnstiel | Elevated rail transit guideway with noise attenuators |
| US4093120A (en) | 1977-01-24 | 1978-06-06 | Park Rubber Company | Railroad crossing structure |
| DE7711191U1 (de) | 1977-04-07 | 1978-09-28 | Straetner Geb. Buss, Anita, 4300 Essen | Fahrbahnplatte fuer schienengleiche bahnuebergaenge |
| DE7719283U1 (de) | 1977-06-20 | 1977-10-27 | Gummiwerk Kraiburg Gmbh & Co, 8264 Waldkraiburg | Platte fuer schienengleiche bahnuebergaenge |
| DE3602313A1 (de) * | 1986-01-27 | 1987-07-30 | Clouth Gummiwerke Ag | Schallabsorbierender laermschutz insbesondere fuer schotterlose gleise |
| DE3827547C2 (de) * | 1988-08-13 | 2000-09-21 | Zueblin Ag | Schallabsorptionskonstruktion für schotterlose Eisenbahnoberbauten |
| US4960184A (en) * | 1989-11-09 | 1990-10-02 | Bruce Woodward | Sound absorbing structure |
| DE4243102A1 (en) * | 1991-12-20 | 1993-07-01 | Bold Karl Gmbh & Co | Noise protection and sight wall with carrier girder construction |
| DE69405881T2 (de) * | 1994-02-11 | 1998-03-19 | Autostrade Concess Const | Schalldämpfender strassenbelag und verfahren zu dessen herstellung |
| DE4414566C2 (de) * | 1994-04-27 | 1997-11-20 | Freudenberg Carl Fa | Luftschalldämpfer |
| DE4417402A1 (de) | 1994-05-18 | 1995-11-23 | Gruenzweig & Hartmann Montage | Schallschutzeinrichtung zur Schalldämpfung und -dämmung an Gleiskörpern |
| NL194553C (nl) * | 1994-06-06 | 2002-07-02 | Veldhoen Raalte B V | Inrichting voor de geluidsisolatie van een spoorbaan. |
| DE29515935U1 (de) * | 1995-10-07 | 1995-11-30 | Deutsche Asphalt GmbH, 63263 Neu-Isenburg | Schallabsorber für einen schotterlosen Eisenbahnoberbau |
| IT1293307B1 (it) * | 1997-07-09 | 1999-02-16 | Dieselbox Sa | Barriera antirumore a pannelli trasparenti,dotata di caratteristiche fonoisolanti e fonoassorbenti |
-
1997
- 1997-05-19 TW TW086106684A patent/TW345603B/zh not_active IP Right Cessation
- 1997-05-23 DK DK97922748T patent/DK0901536T3/da active
- 1997-05-23 AU AU28801/97A patent/AU738889B2/en not_active Ceased
- 1997-05-23 US US09/194,505 patent/US6253872B1/en not_active Expired - Lifetime
- 1997-05-23 HU HU9903612A patent/HU221872B1/hu not_active IP Right Cessation
- 1997-05-23 ES ES97922748T patent/ES2186891T3/es not_active Expired - Lifetime
- 1997-05-23 CA CA002255946A patent/CA2255946C/en not_active Expired - Fee Related
- 1997-05-23 AT AT97922748T patent/ATE229595T1/de active
- 1997-05-23 JP JP54125697A patent/JP3822641B2/ja not_active Expired - Fee Related
- 1997-05-23 CN CNB971950490A patent/CN100424268C/zh not_active Expired - Fee Related
- 1997-05-23 WO PCT/AT1997/000109 patent/WO1997045592A1/de not_active Ceased
- 1997-05-23 EP EP97922748A patent/EP0901536B1/de not_active Expired - Lifetime
- 1997-05-23 DE DE59708955T patent/DE59708955D1/de not_active Expired - Lifetime
-
1998
- 1998-11-30 NO NO19985600A patent/NO316078B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP3822641B2 (ja) | 2006-09-20 |
| EP0901536A1 (de) | 1999-03-17 |
| NO316078B1 (no) | 2003-12-08 |
| ES2186891T3 (es) | 2003-05-16 |
| WO1997045592A1 (de) | 1997-12-04 |
| CA2255946A1 (en) | 1997-12-04 |
| AU738889B2 (en) | 2001-09-27 |
| US6253872B1 (en) | 2001-07-03 |
| HUP9903612A2 (hu) | 2000-02-28 |
| HUP9903612A3 (en) | 2001-08-28 |
| NO985600L (no) | 1998-11-30 |
| CA2255946C (en) | 2006-03-14 |
| CN100424268C (zh) | 2008-10-08 |
| HU221872B1 (hu) | 2003-02-28 |
| TW345603B (en) | 1998-11-21 |
| DK0901536T3 (da) | 2003-04-07 |
| CN1219989A (zh) | 1999-06-16 |
| AU2880197A (en) | 1998-01-05 |
| DE59708955D1 (de) | 2003-01-23 |
| JP2000510921A (ja) | 2000-08-22 |
| NO985600D0 (no) | 1998-11-30 |
| ATE229595T1 (de) | 2002-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0901536A1 (de) | Schallschutzeinrichtung für gleise | |
| EP2817457B1 (de) | Lärmschutzvorrichtung | |
| EP0904461B1 (de) | Schienengleiche eindeckung für gleise | |
| DE2321676A1 (de) | Schallschutzwand aus gummi-verbundwerkstoffen | |
| EP0214524B1 (de) | Mauerwerk- oder Pflasterstein aus Beton oder dergleichen | |
| DE4220547A1 (de) | Laermschutzelement fuer laermschutzwaende | |
| DE19620731A1 (de) | Feste Fahrbahn für schienengebundene Fahrzeuge auf Brücken und Verfahren zu ihrer Herstellung | |
| DE102007037339A1 (de) | Gabionenkorb mit lärmdämmender, monolithischer Schicht aus Beton | |
| DE4430769C2 (de) | Eisenbahnoberbau mit einem auf einer durchgehenden Tragplatte aus Stahlbeton aufgelagerten Gleisrost | |
| DE3827547C2 (de) | Schallabsorptionskonstruktion für schotterlose Eisenbahnoberbauten | |
| DE3134473A1 (de) | Schotterloser oberbau fuer schienenbahnen | |
| DE202011052057U1 (de) | Lärmschutzvorrichtung | |
| AT512523B1 (de) | Fundamentlose Lärmschutzvorrichtung | |
| DE3544481A1 (de) | Schallschutzwand und dafuer geeignetes wandelement | |
| DE19732904A1 (de) | Schallschutzwand zur Dämmung von Schallemissionen von Verkehrsmitteln | |
| EP1721045B1 (de) | Störschall mindernde gleiseindeckung | |
| DE3727947A1 (de) | Schallabsorbierendes bauelement sowie verfahren zur herstellung desselben | |
| AT403809B (de) | Schallschutzeinrichtung für gleise | |
| DE19540357C1 (de) | Eisenbahnbrücke und Kulisse zur Schalldämpfung an dieser | |
| DE19635788A1 (de) | Schalldämpfungselement für Schienentrassen mit fester Fahrbahn | |
| EP1136622B1 (de) | Gleiseindeckung | |
| AT512391B1 (de) | Lärmschutzvorrichtung | |
| EP0166719A2 (de) | Profildichtung | |
| DE29519169U1 (de) | Vorrichtung zur Schalldämpfung einer festen Fahrbahn und damit ausgerüstete feste Fahrbahn | |
| EP1170419A2 (de) | Schallgedämmter, schotterloser Gleisoberbau sowie Schallabsorptionselement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19981130 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT CH DE DK ES FI FR GB IT LI LU PT SE |
|
| AX | Request for extension of the european patent |
Free format text: SI PAYMENT 981130 |
|
| 17Q | First examination report despatched |
Effective date: 20000830 |
|
| GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
| GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
| GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
| GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT CH DE DK ES FI FR GB IT LI LU PT SE |
|
| AX | Request for extension of the european patent |
Free format text: SI PAYMENT 19981130 |
|
| REF | Corresponds to: |
Ref document number: 229595 Country of ref document: AT Date of ref document: 20021215 Kind code of ref document: T |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REF | Corresponds to: |
Ref document number: 59708955 Country of ref document: DE Date of ref document: 20030123 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: A. BRAUN, BRAUN, HERITIER, ESCHMANN AG PATENTANWAE |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
| GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20030329 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2186891 Country of ref document: ES Kind code of ref document: T3 |
|
| ET | Fr: translation filed | ||
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20030912 |
|
| REG | Reference to a national code |
Ref country code: SI Ref legal event code: IF |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: GMUNDNER FERTIGTEILE GESELLSCHAFT M.B.H. & CO. KG Free format text: GMUNDNER FERTIGTEILE GESELLSCHAFT M.B.H. & CO. KG.#KUFERZEILE 30-32#A-4810 GMUNDEN (AT) -TRANSFER TO- GMUNDNER FERTIGTEILE GESELLSCHAFT M.B.H. & CO. KG.#KUFERZEILE 30-32#A-4810 GMUNDEN (AT) |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20120529 Year of fee payment: 16 Ref country code: DK Payment date: 20120522 Year of fee payment: 16 Ref country code: LU Payment date: 20120530 Year of fee payment: 16 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20120529 Year of fee payment: 16 Ref country code: GB Payment date: 20120425 Year of fee payment: 16 Ref country code: SE Payment date: 20120518 Year of fee payment: 16 Ref country code: FI Payment date: 20120523 Year of fee payment: 16 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20120516 Year of fee payment: 16 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20120730 Year of fee payment: 16 Ref country code: ES Payment date: 20120504 Year of fee payment: 16 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PT Payment date: 20120427 Year of fee payment: 16 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20120525 Year of fee payment: 16 |
|
| REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20131125 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| REG | Reference to a national code |
Ref country code: SE Ref legal event code: EUG |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 229595 Country of ref document: AT Kind code of ref document: T Effective date: 20130531 |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20130523 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130531 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130531 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130531 Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130524 Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131125 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131203 |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP Effective date: 20130531 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 59708955 Country of ref document: DE Effective date: 20131203 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130523 Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130523 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20140131 |
|
| REG | Reference to a national code |
Ref country code: SI Ref legal event code: KO00 Effective date: 20140225 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130523 Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130531 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130531 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20140610 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130524 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130523 |